Cargando…
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Enhanced lipid biosynthesis is a characteristic feature of cancer. Deregulated lipogenesis plays an important role in tumour cell survival. These observations suggest that enzymes in the lipid synthesis pathway would be rational therapeutic targets for cancer. To this end, we review the enzymes in d...
Autores principales: | Mashima, T, Seimiya, H, Tsuruo, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694429/ https://www.ncbi.nlm.nih.gov/pubmed/19352381 http://dx.doi.org/10.1038/sj.bjc.6605007 |
Ejemplares similares
-
The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006) -
Roles of vitamin A in the regulation of fatty acid synthesis
por: Yang, Fu-Chen, et al.
Publicado: (2021) -
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021) -
Marine polyunsaturated fatty acids and cancer therapy
por: Vaughan, V C, et al.
Publicado: (2013) -
De novo lipogenesis in metabolic homeostasis: More friend than foe?
por: Solinas, Giovanni, et al.
Publicado: (2015)